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Background: Breast cancer incidence in African population is low compared to western countries but the mortality
rate is higher and the disease presents at a younger age and at a more advanced stage. The World Health
Organisation and the Breast Health Global Initiative concluded that in low and middle income countries early breast
cancer detection can be achieved by informing women on symptoms of breast cancer, on the practice of breast
self-examination and clinical breast examination by trained health care workers. Based on these recommendations, we
set up a breast cancer awareness campaign in Kinshasa, Democratic Republic of Congo (DRC). This paper describes
the strategy that was established and the results that were achieved.
Methods: A breast cancer awareness campaign was started in 2010 and data were collected until the end of 2012.
Clinicians (expert group) trained nurses and health care workers (awareness groups) on clinical, technical and social
aspects of breast cancer. Different channels were used to inform women about the campaign and clinical data
(on medical and family history) were collected. The participating women were investigated with clinical breast
examination by the awareness group. Women in whom a palpable mass was detected were referred to the hospital:
they received a mammography and ultrasound and – in case of suspicious findings – additionally a core needle
biopsy. In case of a positive family history, a blood sample was taken for genetic investigation.
Results: In total, 4,315 women participated, resulting in 1,113 radiological breast examinations, performed in the
General Hospital of Kinshasa of which 101 turned out to be malignant lesions. Fifty six percent of the women with
breast cancer were less than 50 years old and 75% (65/87) were stage III tumors. A BRCA gene mutation was identified
in a family with a severe history of breast cancer.
Conclusions: Even without financial support, it was possible to start an awareness campaign for breast cancer in
Kinshasa. This campaign increased the awareness on cancer of the women in Kinshasa. The results demonstrate that
this campaign had an immediate impact on patients and their families.
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An estimated total of 1,676,633 females were diagnosed
with breast cancer globally in 2012 corresponding to an age
standardized breast cancer incidence rate worldwide of 43.3
cases per 100,000 women and a mortality rate of 12.9 per
100,000, while in Europe the incidence rate of breast cancer
is 94.2 per 100,000 and the mortality rate 22.4 per 100,000
[1]. In contrast with Europe the incidence rate in Sub-
Saharan Africa is 25.5 per 100,000 and the mortality rate
19.3 per 100,000; for the Democratic Republic of Congo
(DRC) the incidence rate is 23.5 per 100,000 and the mor-
tality rate 14.2 per 100,000, showing a 4 times lower inci-
dence but slightly lower mortality rate.
Considering population growth and aging, the incidence
in breast cancer rates is rapidly increasing in Africa. In
Uganda, for example, breast cancer incidence rate has dou-
bled from 11 per 100,000 in 1961 to 22 per 100,000 in
1995 and increased from 18 per 100,000 to 31 per 100,000
in the period between 1991 and 2006 [2,3].
Sylla et al. concluded that the incidence of cancer in
Africa will increase tremendously solely due to demo-
graphic changes whilst that Africa is the least prepared
continent to face this growth in cancer burden [4].
The recording of the occurrence of breast cancer is im-
portant to obtain a correct view on the prevalence of these
cancers. However, few African countries have a cancer
registry and the mature registries cover only a small popu-
lation [1,3,5].
Despite the relatively low breast cancer rate among
African women, the mortality rate is disproportionately
high [6]. The reason of this high mortality rate is multifac-
torial: aside from the cultural aspect, namely the shortage
of awareness among women and the lack of prioritization
by the government, the lack of financial funding leads to a
lack of diagnosis and treatment. Hence, many women are
influenced by traditional healers and charlatans who have
no clinical knowledge of malignant and benign breast
pathologies [3-7].
Epidemiologically, the age at presentation is lower in
Africa (mean age of 48 years) compared to Europe (mean
age is 67 years in British white women) and breast cancer
disease is more often stage III and IV [6,8-10]. It is unclear
whether the presentation at younger age and the more ag-
gressive type of breast cancer in African women can be
attributed to a genetic predisposition. Although some re-
search was done in the African-American group, no scien-
tific data exist on the prevalence of BRCA1 and BRCA2
gene mutations in Central Africa [8,9].
As in many sub-Saharan countries, there is no national
screening program for breast cancer in DRC [1].
The World Health Organisation (WHO) defines a na-
tional cancer control program as “a public health pro-
gram designed to reduce the number of cancer cases
and deaths and improve quality of life of cancer patients,through the systematic and equitable implementation of
evidence-based strategies for prevention, early detection,
diagnosis, treatment, and palliation, making the best use
of available resources” [11].
However, a national cancer program based on a breast
cancer screening test such as mammography is often not
applicable in low income countries: the women are not
aware of the pathology “cancer”, the medical equipment
for the diagnosis of breast cancer is not available and
there is no funding for the diagnostic or therapeutic in-
terventions. The WHO reports that low and middle in-
come countries (LMICs) have the option to implement
early diagnosis programs based on awareness of signs
and symptoms of breast cancer with prompt referral to
diagnosis and treatment [12].
The Breast Health Global Initiative (BHGI) empha-
sizes the necessity of education for the set-up of an
awareness program. This should be done by providers
who first need to obtain the technical knowledge of
breast self-examination (BSE) and clinical breast exam-
ination (CBE) while a basic level of knowledge of path-
ology and therapy should be available [13-16]. Bridges
et al. described the different steps in order to come to a
successful campaign on breast awareness and early de-
tection more comprehensively [17].
This comprehensive ‘Framework for National Breast
Cancer Control’ strategy consists of four themes: 1)
building capacity, 2) developing evidence, 3) removing
barriers and 4) promoting advocacy. Building capacity
involves the training of nurses and relies on the creation
of capacity for national public education. Concerning de-
veloping evidence, a description of the local etiology and
the possibility of personalized treatment of breast cancer
should be branched out. In the third theme, removing
the barriers, insufficient access due to excessive costs for
the patient to high patient related costs and the lack of
access to the program of rural populations need to be
solved. Finally, the fourth theme, promoting advocacy,
focuses on survivors, quality of life, management of
metastatic disease and support for leadership and staff-
ing of advocacy groups.
Based on the information from the WHO, the BHGI
and the paper of Bridges et al. it was concluded that
health education messages must include the idea that
breast cancer is curable in the majority of women pro-
vided that it is detected early, diagnosed accurately, and
treated appropriately. To optimize successful outcome,
communication methods need to be adapted to the cul-
tural boundaries and taboos that invariably surround
breast cancer, keeping in mind that those may differ
among and within countries, depending on the social
context and common healthcare systems [18].
The aim was to design a breast cancer awareness cam-
paign in the DRC based on information (on early signs
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nosis. The program was initiated by an interdisciplinary
working group including oncologic surgeons, radiolo-
gists and nurses.
Methods
The study has been approved by the ethics committee of
the General Hospital of Kinshasa (GHK). All women
who participated in this study have been informed about
the procedures, filled out and signed the relevant ques-
tionnaire and informed consent forms.Expert group (n=4
radiologist, surgeon/onc
gynaecologist, techn
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Figure 1 Organisation of the breast cancer awareness campaign.Strategy
Present study was realized in the department of medical
imaging of the general reference hospital of Kinshasa.
This is the largest hospital in DRC with a capacity of
2,500 beds and a medical staff of 186 physicians. The
hospital has a tertiary function.
The first step was the creation of an “expert group”
possessing the required knowledge for the diagnosis and
treatment of breast cancer and therefore able to provide
a structure for the training of nurses and medical
personnel. The expert group consisted of a radiologist, a)
ologist,
ician
16)
 oncology
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Table 1 Adjusted clinical stages of breast cancer in DRC
Clinical
stage
Description
Stage 0 Absence of mass in the breast, but presence of a
suspicious malignant lymph node
Stage I A mass with a diameter less than 2 cm, without lymph
nodes (documented on mammography or ultrasound)
Stage II a mass with a diameter between 2 cm and 5 cm without
lymph nodes (documented on mammography or
ultrasound)
Stage III A mass of more than 5 cm with the presentation of
enlarged malignant lymph node clinically (documented
on ultrasound)
Stage IV The cancer shows an ulcerated mass with multiple lymph
nodes that were pathologically enlarged and distant
metastases*
*These patients received no additional biopsies but were immediately referred
to the medical oncologist.
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physicians received training for at least 3 months at the
KU Leuven Belgium (Figure 1). The expert group was in
charge of the content of the education material and also
for the composition of the awareness group who would
do the teaching during the campaign.
The latter group included nurses and technicians who
underwent a specific training in clinical examination of
the breast, in auto-palpation and in providing information
and education during the campaign [15]. A number of
seminars were organized in the hospital for the physicians
working in the radiology department, as well as for the
nurses working in the oncology department in order to in-
form them on the different aspects of cancer in general,
but also on how to diagnose and treat breast cancer. Fi-
nally the awareness group consisted of 6 technicians re-
sponsible for the mammographic examinations in the
imaging department, 4 nurses from the oncology depart-
ment, 3 residents from the radiology department and 3
residents from the oncology department. This group was
complemented by two operated breast cancer patients
who volunteered to participate in the campaign. The
awareness group was split in two or three smaller groups
of 5–6 persons, when several information sessions where
planned on the same day. In these smaller groups, at least
one medical doctor was present to answer more difficult
medical questions.
The recruitment procedure
The breast cancer awareness campaign was set up in
Kinshasa in March 2010 and data were collected until the
end of 2012. The channels to organize the awareness in-
cluded television, radio, churches- and women organiza-
tions. To attain a large number of women we focused on
religious meetings including conventional churches as well
as the more recent popular Pentecostal churches which
are mainly frequented by women. Before the start of the
sessions, one person of the awareness group was
appointed for the counting of the participants.
Each information session consisted of a general intro-
duction on cancer, followed by a more detailed explan-
ation on breast cancer. We focused on the importance
of early detection, of all frequently occurring cancers in
women but also on cancers in men such as prostate can-
cer. The posters contained images of cancer in both
women and men. For women, the information focused
on the necessity to consult a hospital for diagnosis and
treatment rather than a center of witchdoctors.
Other posters described the method of auto palpation
and the clinical examination performed by a health care
worker. Detailed information on the treatment of breast
cancer was provided to retain women from consulting
traditional healers and other non-medical healers. The
messages on the posters were kept simple and clear toalso reach women with limited levels of education. The
awareness group not only focused on meetings for
women but also on groups in which men were partici-
pating. Some sessions were even organized for couples:
in total one fourth to one fifth of the people attending
the sessions were men. These men also asked questions
related to cancer occurring in the male population.
Where possible the posters were replaced by slide
presentations.
The meetings were announced on television and radio.
During a presentation on television, the technique of mam-
mography and ultrasound were explained and one of the
patient explained about the organization and the goal of
the sessions. On the radio the breast cancer awareness
campaign was always presented by a radiologist who de-
scribed the different early signs of breast cancer, the im-
portance of breast self-examination and the difference
between diagnosis and therapy in hospitals compared to
witchcraft.
Each meeting started and ended with a question-answer
session presided by a healthcare professional. After the in-
formation session, rudimentary examination rooms were
set up and all participating woman were examined by a
trained member of the awareness group.
The range of ages included in the study was from
18 years upwards. Male patients were excluded from
present study.
Women with a palpable lesion were advised to consult
the GHK, for further diagnostic work-up (mammog-
raphy, ultrasound and biopsy). When a lesion was found,
a core needle biopsy was performed.
Since most women could not afford an additional bi-
opsy, only mammograms with the conclusion BIRADS
3, 4 and 5 were included in the study; the radiological
examination with conclusion BIRADS 1 and 2 were ex-
cluded for further data collection and investigation [19].
For the TNM staging, only the clinical and radiological
Figure 2 Map of the Democratic Republic of Congo and of Kinshasa (capital). 2a/Kinshasa (in red): 8,415,000 inhabitants, Bas-Congo
(in green): 3,500,000 inhabitants with 1 = Kimpese, 2 = Matadi, 3 = Boma, 4 = Muanda. 2b/Kinshasa, capital with 24 communes.
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Figure 3 Evolution of the number of mammograms (2009 till
2012).
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nodes was not always available and most of the surgical
excised lesions were not all histologically investigated,
therefore pathological staging was not possible [20,21].
Regarding the clinical staging, the diameter of the
tumor was recorded for all patients, and in order to
compensate for the absence of pathological information,
the radiological measurements were included in the sta-
ging. Due to the above mentioned problems, the descrip-
tion of the stages of the patients diagnosed in the DRC
was different compared to the international TNM code
(Table 1).
The collected data were analyzed in order to identify
the variations in the etiology of the disease, but because
of the organization of the study, no further conclusion
on the incidence is made in this study. For all women di-
agnosed with breast cancer, family history was recorded
and these family members were investigated. Blood sam-
ples were obtained for BRCA gene mutation screening.
Genetic analysis
The genetic analysis was performed as described by
Michils et al. [22]. During the data collection blood sam-
ples from a 29-year old patient with breast cancer, her
affected mother and her aunt were taken for mutation
analysis of the BRCA1 and BRCA2 genes.
Results
During the breast cancer awareness campaign a total of
64 women organizations and churches were visited: in
the first year we visited 23 of them on our own initiative,
in the second year, after having heard about our initia-
tive, woman organizations and churches invited us for
more information sessions. In the beginning, the cam-
paign focused mainly on the capital Kinshasa with
8,415,000 inhabitants. In July 2012 we started to enlarge
the reach of our campaign to the province of Bas-Congo
(3,500,000 inhabitants) and we gave info sessions in
Kimpese, Matadi, Boma and Muanda. The number of
women visiting the campaign was 3,692. In July 2012 the
awareness group reached another 623 women living
along the motorway between Kinshasa and Muanda at
the Atlantic Ocean (Figure 2a and 2b). The total number
of women reached to date amounts to 4,315 and in 497
of these 4,315 women a palpable mass was found by the
awareness group (CBE). Of these 497 women 133 con-
sulted the radiology department of the GHK and were
all diagnosed with BIRADS 3, 4, 5 lesions. Information
on the 364 women with a palpable mass who did not
present at the hospital was lost during follow up. Mean-
while, the breast examinations in the GHK increased
from 312 in 2010 to 416 at the end of 2012, with a total
of 1,113 mammography examinations in the studied
period (Figure 3). Additionally, 34 lesions were diagnosedwith BIRADS 3, 4, 5 in patients who were informed about
this campaign by women out of the awareness group: a
total of 167 lesions were biopsied [19]. In Table 2 demo-
graphic characteristics of women with BIRADS 3, 4 and 5
are summarized.
The other 946 patients were diagnosed as normal or
benign and in order to minimalize the number of un-
necessary procedures, no further biopsies were done.
One malignant lesion was excluded from the whole
study as only cytology was performed to diagnose the le-
sion. Of the 167 lesions which were correctly biopsied,
100 were found to be malignant, 66 were benign lesions,
1 was normal. Of the malignant lesions 87 (87%) were
invasive tumors and 13 (13%) in situ carcinomas. The
age distribution of these 87 women with malignant le-
sions was as follows: 5 (5.7%) were between 20 and
30 years old, 12 (13.8%) between 31 and 40 years old, 32
(36.8%) between 41 and 50 years old, 23 (26%) between
51 and 60 years old and 15 (17.7%) were more than
60 years old (Figure 4). The clinical stage distribution for
the 87 invasive tumors was: 1 at stage 0 (1%), 2 at stage
I (2%), 19 at stage II (22%), 65 at stage III (75%)
(Table 3).
Genetic analysis
One family with breast cancer at young ages was identi-
fied. Genetic analysis revealed the presence, in the het-
erozygous state, of the c.2389_2390 delGA mutation in
the BRCA1 gene in all 3 members (Figure 5). The muta-
tion leads to a frame shift at codon 797 of the BRCA1
gene (p.Glu797fs).
Discussion
The incidence of cancer in developing countries is in-
creasing mainly because of a population growth, a better
control of infectious disease leading to an aging popula-
tion and a better economic situation leading to a change
of lifestyle [6]. Amir et al. reported a decrease in breast
cancer incidence during the 1968–1996 AIDS epidemic
Table 2 Socio-demographic characteristics of women
diagnosed with BIRADS 3, 4, 5 (mammography,
ultrasound) in the GHK in Kinshasa and Bas-Congo (DRC)
Socio-demographic characteristics n = 167 %
Age (years)
Under 26 2 1.2
26-33 10 6
34-45 43 25.8
>45 112 67
Missing values 0 0
Age at menarche (years)
11-13 41 24.5
14-15 111 66.5
16-18 15 9
>18 0 0
Missing values 0 0
Education
Illiterate 0 0
Primary school 28 16.8
Secondary school 100 60
Higher 39 23.2
Missing values 0 0
Marital status
Single 60 36
Married 75 45
Divorced/separated 3 1.8
Widowed 29 17.2
Missing values 0 0
Occupation of the woman (profession)
Housewife 87 52
Manual labor 35 21
Medical doctor 2 1.2
Nurse 8 4.8
Student 1 0.6
Other 34 20.4
Missing values 0 0
Number of children
0 41 24.5
1-3 53 31.8
4-5 42 25.1
>5 31 18.6
Missing values 0 0
Table 2 Socio-demographic characteristics of women
diagnosed with BIRADS 3, 4, 5 (mammography,
ultrasound) in the GHK in Kinshasa and Bas-Congo (DRC)
(Continued)
Family history of breast cancer
Yes 9 5.4
No 157 94
I don not know 1 0.6
Missing values 0 0
Personal history of breast disease
Yes 17 10.2
Ovarian 4 2.4
Uterus 16 9.6
No 130 77.8
Missing values 0 0
Religion
Christian 162 97
Muslim 0 0
Other/no religion 5 3
Missing values 0 0
Motivation for consulting
Church 96 57.6
Family members 10 6
Radio 1 0.6
Television 3 1.8
Women organization 37 22
Other 20 12
Missing values 0 0
3 years age standardized relative survival
Yes 137 82
No (died) 28 16.8
Missing values 2 1.2
n = total number of participants.
% = percentage of participants.
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once HIV was under control, women became older and
cancer incidence was increasing [23]. In order to map
the problem of breast cancer in women of Central Af-
rica, a breast cancer control strategy based on breast
cancer awareness, BSE and CBE was set up in the DRC.
The implementation of this breast cancer control strat-
egy resulted in an awareness campaign attended by more
than 4,000 women in and around Kinshasa. As a result
of the campaign, the number of women presenting at
the hospital with a palpable lump increased significantly,
while in the years before the campaign women were first
seeking help in non-medical health services (witchdoc-
tors). With more women presenting themselves with
breast related problems at the hospital the expertise in
Figure 4 Distribution of breast cancer for the different age categories.
I.1 I.2
II.1 II.2 II.3 II.4
50y
I.3 I.4
II.5 II.6
III.2
52y
III.3
48y
III.4
40y
III.1 III.5
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laboration between clinicians and health care workers
was achieved. In the department of imaging there was a
significant increase in mammogram and ultrasound ex-
aminations. More than one thousand (1,113) radiological
breast examinations were performed: 167 were con-
cluded as BIRADS 3, 4, 5 and 100 cancers were detected
(59% true positives). The detection rate in our study is
higher compared to the results of Abruidis et al. [24]. In
his study, in which an awareness program, for both men
and women, was implemented in different villages in
Soudan, 10,309 women were screened by CBE. Only 138
women were identified with breast abnormalities and re-
ferred to the hospital for further diagnosis. Of these 138
women, 118 were diagnosed: 101 with benign lesions, 8
with DCIS and 9 with invasive carcinoma (12% true pos-
itives). This difference can be attributed to the training
of the health care workers in the awareness group of
Kinshasa (better trained), the educational status of the
women (rural versus non-rural situation) and to more
practical issues (accessibility to the hospital). Informa-
tion on cancer and BSE together with CBE resulted in a
better detection of the early signs of breast cancer. This
is in accordance with the findings of Mena et al. on
the assessment of the impact of the Ghanaian non-
governmental Breast Care International program onTable 3 Clinical stage distribution of invasive breast
carcinomas
Clinical stage (n = 87) n (%)
Stage 0 1 (1)
Stage I 2 (2)
Stage II 19 (22)
Stage III 65 (75)knowledge, attitudes and practices toward breast cancer
in rural Ghana. In this paper the investigator concluded
that the knowledge of the referent group on breast can-
cer appearing as a painless lump was only 53.3%, com-
pared to the 82.3% of the intervention group, moreover
the latter participants obtain significantly higher know-
ledge scores (odds ratio = 2.1, 95% confidence interval =IV.1 IV.2 IV.3
29y
Figure 5 Pedigree of the family that underwent BRCA1/2
genetic testing. The age of disease presentation is indicated. The
arrow refers to the index patient; blacked-in shapes indicate a breast
cancer diagnosis.
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95% CI: 5.31-28.48) [25].
Detailed analysis of our results showed that 56% of the
cancers presented at an age between 30 and 50 years
old. These results correlate with the data from Fregene
et al., Basro et al. and Gukas et al. who stated that breast
cancer incidence peaks between the ages of 35 and
45 years. This is approximately 10 to 15 years earlier
than the peak incidence of western countries outside the
western African region [6,9,26,27]. Furthermore, 75% of
the invasive tumors presented at stage III which is in
agreement with studies conducted in Libya, Nigeria and
Tanzania [28,29].
We recognize that the present study has several limita-
tions. A major one is that not all lesions seen on mam-
mography or ultrasound were biopsied (only BIRADS 3,
4 and 5 lesions), nor a follow up of more than one year
for the BIRADS 1 and 2 lesions was available. We realize
that with this approach, some tumors might have been
missed, but on the other hand - within the difficult
financial context - we maximized the detection of the
number of potentially treatable malignancies. However
one consequence of this compromise is that the true in-
cidence of breast cancer in the examined population is
underestimated. Another limitation is the absence of an
evaluation of the impact of the breast cancer awareness
campaign on the knowledge of cancer and of the early
signs of breast cancer in the participating women. But
the increase of the number of women attending the ses-
sions in churches and the increasing demand for new
sessions suggest an improvement of the awareness in the
population. Moreover, there is also a continuous and on-
going increase of women attending the mammography
department.
In one family, a mutation was identified in the BRCA1
gene (c.2389_2390 delGA, p.Glu797fs). This mutation is
predicted to lead to a truncated and non-functional pro-
tein and is therefore the cause of the disease in this pa-
tient and her family. This mutation is described in the
Breast Cancer Information Core database and was ini-
tially identified in other patients of African origin [30].
Nevertheless, to the best of our knowledge, this is the
first report of the diagnosis of a BRCA mutation carrier
in DRC.
Despite the absence of any financial support for the
campaign by the government, breast cancer awareness
among the population increased and more women
searched medical help. The goal of the campaign was
also to inspire officials and local authorities to put breast
cancer on the agenda of women’s health.
This campaign, even if it is only a start of a more
widely introduced cancer campaign, will certainly have
an impact on women’s health: Koon et al. demonstrated
that advocacy and education, in particular through theefforts of breast cancer survivors and their partners, can
play a crucial role in improving overall outcomes in de-
veloping countries [31].
Conclusion
Introducing a breast cancer awareness campaign in the
Democratic Republic of Congo, based on information by
well-educated health care workers, breast self-examination
and clinical breast examination, resulted in an increase of
women looking for diagnosis and treatment in the hospital
instead of consulting non-medical health care workers like
witchdoctors. With an annual or bi-annual information
day, knowledge on breast cancer can clearly reach out to
more women and with some financial involvement of the
government more women can be diagnosed at an earlier
stage.
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